1

The New Targeting interleukin-8 Agent ABX-IL8: A Targeted Therapy

abx-il8-reference-antibo370061
Recent studies are a promise of ABX-IL8, a novel compound engineered to specifically inhibit interleukin-8 (IL-8), a crucial inflammatory mediator implicated in multiple chronic conditions https://www.targetmol.com/compound/abx_il8
Report this page

Comments

    HTML is allowed

Who Upvoted this Story